Anyone interested in Profound Medical Corp. (TSE:PRN) should probably be aware that the Independent Lead Director, Brian Ellacott, recently divested CA$195k worth of shares in the company, at an average price of CA$10.85 each. That sale was 25% of their holding, so it does make us raise an eyebrow.
Notably, that recent sale by Brian Ellacott is the biggest insider sale of Profound Medical shares that we've seen in the last year. So we know that an insider sold shares at around the present share price of CA$10.60. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.
Over the last year, we can see that insiders have bought 100.30k shares worth CA$941k. On the other hand they divested 18.00k shares, for CA$195k. In the last twelve months there was more buying than selling by Profound Medical insiders. The average buy price was around CA$9.39. To my mind it is good that insiders have invested their own money in the company. However, you should keep in mind that they bought when the share price was meaningfully below today's levels. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
See our latest analysis for Profound Medical
There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 2.8% of Profound Medical shares, worth about CA$11m, according to our data. We do generally prefer see higher levels of insider ownership.
It is good to see recent purchasing. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. When combined with notable insider ownership, these factors suggest Profound Medical insiders are well aligned, and that they may think the share price is too low. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Profound Medical. Every company has risks, and we've spotted 2 warning signs for Profound Medical (of which 1 is significant!) you should know about.
But note: Profound Medical may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.